Hematological patients, including those with chronic and acute myelogenous leukemia, show altered pituitary-thyroid function. Disease progression and treatment impact thyroid hormone levels, sometimes indicating secondary hypothyroidism.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: